In the US and Europe, most instances of hyperparathyroidism are detected incidentally when routine laboratory tests are done.[1]Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4677
http://www.ncbi.nlm.nih.gov/pubmed/36245251?tool=bestpractice.com
Hypercalcaemia and primary hyperparathyroidism (PHPT) are only rarely diagnosed clinically, and the definitive diagnosis relies on laboratory tests. In resource-poor countries, the majority of patients present with symptoms.[6]Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.
https://www.doi.org/10.1038/nrendo.2017.104
http://www.ncbi.nlm.nih.gov/pubmed/28885621?tool=bestpractice.com
History and physical examination
Initial assessment should include both a detailed personal and family history.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
PHPT is 2 to 3 times more common in women than in men.[6]Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.
https://www.doi.org/10.1038/nrendo.2017.104
http://www.ncbi.nlm.nih.gov/pubmed/28885621?tool=bestpractice.com
Prevalence increases with age and is especially common in postmenopausal women.[6]Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.
https://www.doi.org/10.1038/nrendo.2017.104
http://www.ncbi.nlm.nih.gov/pubmed/28885621?tool=bestpractice.com
Symptoms of PHPT are most likely not to be related to hypercalcaemia itself and instead relate to its effect on key target organs.[27]El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, et al. Classical and nonclassical manifestations of primary hyperparathyroidism. J Bone Miner Res. 2022 Nov;37(11):2330-50.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4679
http://www.ncbi.nlm.nih.gov/pubmed/36245249?tool=bestpractice.com
Medical history may reveal a history of skeletal (e.g., osteopenia or osteoporosis) or renal (e.g., kidney stones) involvement.[1]Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4677
http://www.ncbi.nlm.nih.gov/pubmed/36245251?tool=bestpractice.com
There may also be a family history of hyperparathyroidism or, where this was undiagnosed, a family history of conditions suggestive of hypercalcaemia or other endocrine gland involvement.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
Other features such as neuropsychological symptoms (overt neuromuscular dysfunction is now uncommon), cardiovascular disease abnormalities, or gastrointestinal symptoms are considered to be non-specific.[6]Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.
https://www.doi.org/10.1038/nrendo.2017.104
http://www.ncbi.nlm.nih.gov/pubmed/28885621?tool=bestpractice.com
The following non-specific features are most common:
Fatigue
Poor sleep
Myalgias
Anxiety
Depression
Memory loss
Gastrointestinal symptoms that can be attributed to hypercalcaemia, such as anorexia, nausea, vomiting, constipation, and abdominal pain (such as from pancreatitis), are now uncommon and are rarely linked to PHPT.[1]Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4677
http://www.ncbi.nlm.nih.gov/pubmed/36245251?tool=bestpractice.com
[27]El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, et al. Classical and nonclassical manifestations of primary hyperparathyroidism. J Bone Miner Res. 2022 Nov;37(11):2330-50.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4679
http://www.ncbi.nlm.nih.gov/pubmed/36245249?tool=bestpractice.com
Non-specific symptoms that may have been previously attributed to other disorders or ageing may be attributed to hyperparathyroidism once it is diagnosed. Surgical cure may lead to apparent resolution of symptoms; patients who are considered to be asymptomatic sometimes report improvements in quality of life following surgery.[28]McDow AD, Sippel RS. Should symptoms be considered an indication for parathyroidectomy in primary hyperparathyroidism? Clin Med Insights Endocrinol Diabetes. 2018 Jun 27;11:1179551418785135.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043916
http://www.ncbi.nlm.nih.gov/pubmed/30013413?tool=bestpractice.com
Physical examination of the neck is usually unremarkable. A palpable neck mass is rare in benign parathyroid disorders, but may be present in up to 70% of patients with parathyroid carcinoma.[3]Fingeret AL. Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol Pract. 2021 Jan;17(1):17-21.
https://ascopubs.org/doi/10.1200/JOP.19.00540
http://www.ncbi.nlm.nih.gov/pubmed/32040373?tool=bestpractice.com
Laboratory
Diagnosis of PHPT is confirmed with repeat simultaneously matched measurements of serum calcium and serum intact parathyroid hormone (PTH). Repeat measurements are required given that patients with PHPT may occasionally have temporarily normal calcium levels despite being hypercalcaemic most of the time.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
If the patient is being treated with thiazide diuretics, medicine should be stopped 2 weeks before calcium measurements. During blood drawing, venous stasis should be avoided to ensure accurate results. Serum calcium levels should be adjusted for the serum albumin concentration.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[12]Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017 Jan;28(1):1-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206263
http://www.ncbi.nlm.nih.gov/pubmed/27613721?tool=bestpractice.com
This is done by adding 0.20 mmol/L (0.8 mg/dL) to the total serum calcium level for every 10 g/L (1 g/dL) the serum albumin concentration is <40 g/L (4 g/dL).
Intact serum PTH (entire 84-amino acid sequence) is measured by immunoradiometric or immunochemical assay. Of note, if the serum intact PTH level is normal with hypercalcaemia, hyperparathyroidism is not excluded, since it is the appropriateness of the PTH level relative to the calcium level that is relevant.[6]Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.
https://www.doi.org/10.1038/nrendo.2017.104
http://www.ncbi.nlm.nih.gov/pubmed/28885621?tool=bestpractice.com
Patients with normocalcaemic PHPT have normal serum and ionised calcium levels. Therefore, a normal ionised calcium is necessary to establish the diagnosis of normocalcaemic PHPT, but not hypercalcaemic PHPT.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
The 25-hydroxyvitamin D level should also be assessed because a low vitamin D may lead to a physiologically compensatory elevated PTH level that normalises on the repletion of the vitamin.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[12]Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017 Jan;28(1):1-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206263
http://www.ncbi.nlm.nih.gov/pubmed/27613721?tool=bestpractice.com
[29]Weaver S, Doherty DB, Jimenez C, et al. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg. 2009 Nov;33(11):2292-302.
http://www.ncbi.nlm.nih.gov/pubmed/19308641?tool=bestpractice.com
Alkaline phosphatase levels are not necessary for diagnosis, but they might help in determining the extent of the bone disease. Pre-operative elevated alkaline phosphatase levels predict postoperative hypocalcaemia following parathyroidectomy.
Serum phosphorous levels might be in the lower range of normal, indicating concomitant electrolyte shifts. Patients with PHPT may have a low or low-normal blood phosphorus level.
In patients with presumed hyperparathyroidism, urinary calcium measurements should be performed with a 24-hour measurement of urinary creatinine and calcium.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[12]Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017 Jan;28(1):1-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206263
http://www.ncbi.nlm.nih.gov/pubmed/27613721?tool=bestpractice.com
Hypercalciuria is a marker of renal involvement in PHPT. International PHPT guidelines recommend a urinary calcium level of >250 mg/day in women; >300 mg/day in men as an indication for parathyroidectomy, although the UK National Institute for Health and Care Excellence do not recommend referral for surgery based on urinary calcium measurements.[1]Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.
https://asbmr.onlinelibrary.wiley.com/doi/10.1002/jbmr.4677
http://www.ncbi.nlm.nih.gov/pubmed/36245251?tool=bestpractice.com
[30]National Institute for Health and Care Excellence. Hyperparathyroidism (primary): diagnosis, assessment and initial management. 2019 [internet publication].
https://www.nice.org.uk/guidance/ng132
Familial hypocalciuric hypercalcaemia (FHH) can often be differentiated from PHPT by measuring the renal calcium to creatinine excretion ratio, which generally is much lower in patients with FHH than in patients with PHPT due to other causes. FHH should be considered in patients with long-standing hypercalcaemia with urinary calcium levels <100 mg/day, and a calcium to creatinine clearance ratio less than 0.01.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
FHH can be confirmed with genetic testing.[5]Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol. 2022 Feb 1;186(2):R33-63.
https://academic.oup.com/ejendo/article/186/2/R33/6852989
http://www.ncbi.nlm.nih.gov/pubmed/34863037?tool=bestpractice.com
Radiographic studies
The diagnosis of PHPT is based on biochemical parameters. Parathyroid localisation studies serve no purpose in diagnosis, but represent a guide to the operating surgeon once the decision has been made to proceed with parathyroidectomy.[31]Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.
https://www.doi.org/10.1007/s00259-021-05334-y
http://www.ncbi.nlm.nih.gov/pubmed/33839893?tool=bestpractice.com
These studies should not be a surrogate for diagnosis of PHPT and are often deferred to the surgeon to order based on their preference and local hospital's expertise.
In surgical management, pre-operative imaging is used to help localise the suspected adenoma(s). Parathyroid glands are usually located at the 4 poles of the thyroid gland, although they may be found in other locations and can therefore be difficult to locate. Lack of positive imaging is not a reason to avoid carrying out parathyroidectomy in a patient with a clear biochemical diagnosis of PHPT as an experienced parathyroid surgeon will be able to find abnormal parathyroid tissue.[12]Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017 Jan;28(1):1-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206263
http://www.ncbi.nlm.nih.gov/pubmed/27613721?tool=bestpractice.com
[32]Scott-Coombes DM, Rees J, Jones G, et al. Is unilateral neck surgery feasible in patients with sporadic primary hyperparathyroidism and double negative localisation? World J Surg. 2017 Jun;41(6):1494-9.
http://www.ncbi.nlm.nih.gov/pubmed/28116482?tool=bestpractice.com
Several imaging modalities are available. Given the significant regional variation in imaging accuracy, candidates for parathyroidectomy should be referred to an expert clinician to decide on the best imaging modalities based on their knowledge of local imaging availability.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[33]Treglia G, Trimboli P, Huellner M, et al. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods. Minerva Endocrinol. 2018 Jun;43(2):133-43.
http://www.ncbi.nlm.nih.gov/pubmed/28650133?tool=bestpractice.com
[34]Zafereo M, Yu J, Angelos P, et al. American Head and Neck Society endocrine surgery section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019 Jul;41(7):2398-2409.
https://onlinelibrary.wiley.com/doi/10.1002/hed.25781
http://www.ncbi.nlm.nih.gov/pubmed/31002214?tool=bestpractice.com
[35]American College of Radiology. ACR appropriateness criteria. Parathyroid Adenoma. 2021 [internet publication].
https://acsearch.acr.org/docs/3158171/Narrative
Neck ultrasound is the preferred initial localisation study in patients with PHPT.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[34]Zafereo M, Yu J, Angelos P, et al. American Head and Neck Society endocrine surgery section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019 Jul;41(7):2398-2409.
https://onlinelibrary.wiley.com/doi/10.1002/hed.25781
http://www.ncbi.nlm.nih.gov/pubmed/31002214?tool=bestpractice.com
Ultrasonography also identifies concomitant thyroid disease, which is present in 12% to 67% of patients with hyperparathyroidism.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
Many institutions use technetium-99m-sestamibi (MIBI) scanning, often in conjunction with ultrasonography.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
[30]National Institute for Health and Care Excellence. Hyperparathyroidism (primary): diagnosis, assessment and initial management. 2019 [internet publication].
https://www.nice.org.uk/guidance/ng132
[31]Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.
https://www.doi.org/10.1007/s00259-021-05334-y
http://www.ncbi.nlm.nih.gov/pubmed/33839893?tool=bestpractice.com
The use of MIBI single-photon emission computed tomography (SPECT)/CT is commonly used in some areas and has a sensitivity of 88%.[31]Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.
https://www.doi.org/10.1007/s00259-021-05334-y
http://www.ncbi.nlm.nih.gov/pubmed/33839893?tool=bestpractice.com
[36]Treglia G, Sadeghi R, Schalin-Jäntti C, et al. Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck. 2016 Apr;38(suppl 1):E2159-72.
http://www.ncbi.nlm.nih.gov/pubmed/25757222?tool=bestpractice.com
Four-dimensional CT in combination with ultrasound is also used for initial assessment.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
It appears to have at least a similar diagnostic performance compared to tomographic parathyroid scintigraphy and is particularly useful in the case of negative previous imaging studies or in patients with distorted neck anatomy.[31]Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.
https://www.doi.org/10.1007/s00259-021-05334-y
http://www.ncbi.nlm.nih.gov/pubmed/33839893?tool=bestpractice.com
Magnetic resonance imaging (MRI) is an option, although this is less commonly used except in certain circumstances such as pregnancy.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
A systematic review and meta-analysis examined the role of radiolabelled 11C- or 18F-choline PET, combined with CT (PET/CT) or MRI (PET/MRI), for the detection of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism with encouraging results.[37]Treglia G, Piccardo A, Imperiale A, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):751-65.
https://www.doi.org/10.1007/s00259-018-4123-z
http://www.ncbi.nlm.nih.gov/pubmed/30094461?tool=bestpractice.com
Subsequent prospective studies have validated these findings.[38]Manyalich-Blasi M, Domínguez-Garijo P, Saavedra-Pérez D, et al. Comparison of [(18)F]fluorocholine PET/CT with [(99)mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study. Gland Surg. 2022 Nov;11(11):1764-71.
https://gs.amegroups.org/article/view/104364/html
http://www.ncbi.nlm.nih.gov/pubmed/36518798?tool=bestpractice.com
[39]Cuderman A, Senica K, Rep S, et al. (18)F-Fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid Glands. J Nucl Med. 2020 Apr;61(4):577-83.
https://jnm.snmjournals.org/content/61/4/577
http://www.ncbi.nlm.nih.gov/pubmed/31562221?tool=bestpractice.com
[40]Dudoignon D, Delbot T, Cottereau AS, et al. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism. Diagn Interv Imaging. 2022 May;103(5):258-65.
https://www.sciencedirect.com/science/article/pii/S2211568421002825?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/35039246?tool=bestpractice.com
However, large multicentre and cost-effectiveness studies are still needed to clarify the role of this imaging in a clinical setting.
Combining functional and anatomical tests is more effective than any one test alone.
Pre-operative ultrasound-directed fine-needle aspiration biopsy of parathyroid lesions is not routinely recommended and may only be considered in unusual, difficult, or re-operative cases of PHPT and not in suspected parathyroid carcinoma. This is because it is rarely necessary and is associated with a number of potential adverse effects.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
Once diagnosis is confirmed, a dual-energy x-ray absorptiometry (DXA) scan should be completed to assess progression of disease in 3 sites, lumbar spine, hip, and forearm, and serve as a baseline for subsequent postoperative scans. An ultrasound scan of the kidneys will establish whether there is asymptomatic renal calcification. Asymptomatic renal calcification is an indication for parathyroidectomy.[2]Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.
http://jamanetwork.com/journals/jamasurgery/fullarticle/2542667
http://www.ncbi.nlm.nih.gov/pubmed/27532368?tool=bestpractice.com
The trabecular bone score (TBS) is an imaging technology adapted directly from the DXA image of the lumbar spine that provides information about skeletal microstructure. Several studies have assessed TBS in patients with PHPT, and their results suggest that TBS may identify trabecular abnormalities not captured by lumbar spine bone mineral density in PHPT.[41]Ulivieri FM, Silva BC, Sardanelli F, et al. Utility of the trabecular bone score (TBS) in secondary osteoporosis. Endocrine. 2014 Nov;47(2):435-48.
http://www.ncbi.nlm.nih.gov/pubmed/24853880?tool=bestpractice.com
Machine learning to identify primary hyperparathyroidism
Machine learning is a growing field with many different applications. It involves applying a collection of methods that allow a computer to learn rules from known/existing data sets to make predictions. Research has demonstrated a way to diagnose PHPT without a knowledge of calcium or PTH values.[42]Greer ML, Davis K, Stack BC Jr. Machine learning can identify patients at risk of hyperparathyroidism without known calcium and intact parathyroid hormone. Head Neck. 2022 Apr;44(4):817-22.
https://onlinelibrary.wiley.com/doi/10.1002/hed.26970
http://www.ncbi.nlm.nih.gov/pubmed/34953008?tool=bestpractice.com
Some researchers are exploring its use to distinguish between multi-gland disease and single adenomas preoperatively, thereby optimising operative planning.[43]Imbus JR, Randle RW, Pitt SC, et al. Machine learning to identify multigland disease in primary hyperparathyroidism. J Surg Res. 2017 Nov;219:173-9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661967
http://www.ncbi.nlm.nih.gov/pubmed/29078878?tool=bestpractice.com